---

---

results   entities : Lexicon pharmaceuticals, inc.   

save search

---

Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -23.73% | O: 6.91% H: 21.55% C: 21.12%
business update pharmaceuticals results

---

Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-08 (Crawled : 12:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| 32.4% | O: -10.4% H: 10.71% C: 1.79%
business update pharmaceuticals financial results

---

Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023
Published: 2023-11-03 (Crawled : 13:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| 18.21% | O: -1.43% H: 8.7% C: 7.25%
conference pharmaceuticals financial results

---

Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Published: 2023-09-26 (Crawled : 13:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| 56.13% | O: -0.94% H: 14.05% C: 11.43%
lx9211 association meeting diabetes results study

---

Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023
Published: 2023-08-21 (Crawled : 13:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -0.3% | O: 0.0% H: 7.23% C: 4.82%
heart cardiology results study

---

Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-03 (Crawled : 20:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -13.8% | O: -6.25% H: 3.89% C: 3.89%
business update pharmaceuticals financial results

---

Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023
Published: 2023-07-28 (Crawled : 20:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| Email alert Add to watchlist
conference pharmaceuticals financial results

---

Lexicon to Present Study Results Relating to LX9211 and INPEFA™ (Sotagliflozin) at the American Diabetes Association’s 83rd Scientific Sessions
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -31.61% | O: -0.41% H: 0.0% C: -2.07%
lx9211 sessions diabetes results study

---

Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-02 (Crawled : 20:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -30.46% | O: 4.62% H: 11.64% C: 10.04%
business update pharmaceuticals financial results

---

Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023
Published: 2023-04-28 (Crawled : 21:00) - biospace.com/
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -29.87% | O: 0.85% H: 3.57% C: 0.42%
conference pharmaceuticals financial results

---

Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The British Pain Society (BPS) 56th Annual Scientific Meeting 2023
Published: 2023-04-21 (Crawled : 13:20) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -32.45% | O: 2.04% H: 2.4% C: -0.4%
lx9211 meeting trial results

---

Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update
Published: 2023-03-02 (Crawled : 21:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -24.08% | O: 0.92% H: 29.55% C: 21.82%
pharmaceuticals financial update results

---

Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023
Published: 2023-02-28 (Crawled : 22:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -26.44% | O: 0.44% H: 1.77% C: -2.65%
pharmaceuticals conference financial results

---

Lexicon Announces Topline Results From Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia
Published: 2022-12-21 (Crawled : 00:00) - biospace.com/
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -13.8% | O: 0.52% H: 3.63% C: -1.55%
lx9211 topline results study phase 2

---

Lexicon’s LX9211 Shows Significant and Consistent Benefits in the Treatment of Painful Diabetic Neuropathy in Full Results From the Phase 2 RELIEF-DPN-1 Trial Presented at the 16th Annual Pain Therapeutics Summit
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -28.97% | O: 3.43% H: 2.07% C: -3.73%
lx9211 treatment trial therapeutics results benefits diabetic

---

Lexicon Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Business Update
Published: 2022-11-09 (Crawled : 23:00) - biospace.com/
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -19.66% | O: -0.97% H: 0.49% C: -3.92%
pharmaceuticals financial update results

---

Lexicon Pharmaceuticals Highlights Oral Presentation of Final Results From the RELIEF-DPN-1 Trial of LX9211 at the 16th Annual Pain Therapeutics Summit
Published: 2022-11-08 (Crawled : 14:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -22.3% | O: 0.94% H: 0.47% C: -4.19%
lx9211 pharmaceuticals trial therapeutics presentation results

---

New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure
Published: 2022-11-06 (Crawled : 00:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -20.43% | O: 0.96% H: 4.05% C: 1.43%
risk heart

---

Lexicon Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022
Published: 2022-11-04 (Crawled : 13:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -22.66% | O: 0.47% H: 0.47% C: -3.26%
pharmaceuticals conference financial results

---

Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-02 (Crawled : 09:00) - globenewswire.com
LXRX | News | $1.655 1.53% 470K |

Health Technology

| -36.35% | O: 0.38% H: 6.51% C: 3.07%
update results

---

Gainers vs Losers

81%

19%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M |

Finance

EGOX | $0.0835 131.94% 160M |

ZCMD | $2.18 50.35% 24M |

Commercial Services

CHRO | $1.73 41.22% 46K |

n/a

RWOD | $10.61 32.68% 5.1M |

n/a

NVFY | $2.77 31.28% 2.2M |

Consumer Durables

AULT | $0.3174 31.1% 28M |

Manufacturing

WISA 4 | $7.11 20.71% 4.7M |

Electronic Technology

LIFW | News | $0.99 19.26% 800K |

Administrative and Support and ...

PRTG | $0.285 18.75% 140K |

Mining, Quarrying, and Oil and ...

---

Your saved searches

---